This study will test the hypothesis that a 30 minute intravenous infusion of gemcitabine administered weekly for 3 weeks followed by one week of rest can be safely administered to children with solid tumors unresponsive or no longer responsive to standard chemotherapy.
Showing the most recent 10 out of 502 publications